Institute of Clinical Chemistry University of Zurich and University Hospital of Zurich, Zurich, Switzerland.
Department of Pathology and Molecular Pathology, University of Zurich and University Hospital of Zurich, Zurich, Switzerland.
J Lipid Res. 2018 Nov;59(11):2188-2201. doi: 10.1194/jlr.M083311. Epub 2018 Sep 1.
Clear-cell renal cell carcinomas (ccRCCs) are characterized by inactivation of the von Hippel-Lindau (VHL) gene and intracellular lipid accumulation by unknown pathomechanisms. The immunochemical analysis of 356 RCCs revealed high abundance of apoA-I and apoB, as well as scavenger receptor BI (SR-BI) in the ccRCC subtype. Given the characteristic loss of VHL function in ccRCC, we used VHL-defective and VHL-proficient cells to study the potential influence of VHL on lipoprotein uptake. VHL-defective patient-derived ccRCC cells and cell lines (786O and RCC4) showed enhanced uptake as well as less resecretion and degradation of radio-iodinated HDL and LDL (I-HDL and I-LDL, respectively) compared with the VHL-proficient cells. The ccRCC cells showed enhanced vascular endothelial growth factor (VEGF) and SR-BI expression compared with normal kidney epithelial cells. Uptake of I-HDL and I-LDL by patient-derived normal kidney epithelial cells as well as the VHL-reexpressing ccRCC cell lines, 786-O-VHL and RCC4-O-VHL cells, was strongly enhanced by VEGF treatment. The knockdown of the VEGF coreceptor, neuropilin-1 (NRP1), as well as blocking of SR-BI significantly reduced the uptake of lipoproteins into ccRCC cells in vitro. LDL stimulated proliferation of 786-O cells more potently than 786-O-VHL cells in a NRP1- and SR-BI-dependent manner. In conclusion, enhanced lipoprotein uptake due to increased activities of VEGF/NRP1 and SR-BI promotes lipid accumulation and proliferation of VHL-defective ccRCC cells.
透明细胞肾细胞癌 (ccRCC) 的特征是 von Hippel-Lindau (VHL) 基因失活和未知发病机制导致的细胞内脂质积累。对 356 例 RCC 的免疫化学分析显示,ccRCC 亚型中载脂蛋白 A-I 和载脂蛋白 B 以及清道夫受体 BI (SR-BI) 的丰度很高。鉴于 ccRCC 中 VHL 功能的特征性丧失,我们使用 VHL 缺陷和 VHL 功能正常的细胞来研究 VHL 对脂蛋白摄取的潜在影响。与 VHL 功能正常的细胞相比,VHL 缺陷的患者衍生的 ccRCC 细胞和细胞系 (786O 和 RCC4) 显示出增强的摄取,以及放射性碘标记的 HDL 和 LDL(分别为 I-HDL 和 I-LDL)的再分泌和降解减少。与正常肾上皮细胞相比,ccRCC 细胞显示出增强的血管内皮生长因子 (VEGF) 和 SR-BI 表达。VEGF 处理强烈增强了患者衍生的正常肾上皮细胞以及 VHL 重新表达的 ccRCC 细胞系 786-O-VHL 和 RCC4-O-VHL 细胞对 I-HDL 和 I-LDL 的摄取。VEGF 核心受体神经纤毛蛋白 1 (NRP1) 的敲低以及 SR-BI 的阻断显著降低了脂蛋白在体外进入 ccRCC 细胞的摄取。LDL 以 NRP1 和 SR-BI 依赖的方式更有力地刺激 786-O 细胞的增殖,而不是 786-O-VHL 细胞。总之,由于 VEGF/NRP1 和 SR-BI 活性的增加,促进了脂蛋白的摄取,从而导致 VHL 缺陷的 ccRCC 细胞的脂质积累和增殖。